| Toll样受体在肺癌中的研究进展 |
| |
| 引用本文： | 康宝丽,陆英 综述,徐增光审校. Toll样受体在肺癌中的研究进展[J]. 同济大学学报(医学版), 2015, 36(3): 140-144 |
| |
| 作者姓名： | 康宝丽 陆英 综述 徐增光审校 |
| |
| 作者单位： | 同济大学附属东方医院科研部,上海 200120,同济大学附属东方医院科研部,上海 200120,同济大学附属东方医院科研部,上海 200120 |
| |
| 基金项目： | 上海市浦东新区卫生系统领先人才培养计划(PWRL2014-01); 上海市浦东新区科委(PKJ2009-Y05); 上海市科委生物医药领域重点项目(11DZ1973800) |
| |
| 摘 要： | 肺癌是目前全世界癌症死因的第一位。尽管治疗在不断进步,但预后仍然很差。Toll样受体(Toll-like receptors, TLRs)是一种模式识别受体,是非常重要的天然免疫分子。TLRs识别特异性分子以后能调节适应性免疫。通过TLRs激活免疫系统在起到抗肿瘤作用的同时,由于潜在的慢性炎症,又促进了肺癌的进程。越来越多的研究发现TLRs在肺癌中的功能及其分子机制,提示TLRs在肺癌发生、发展中具有重要作用。
|
| 关 键 词： | Toll样受体 炎症 肺肿瘤 免疫系统 |
| 收稿时间： | 2014-06-26 |
Research progress of Toll-like receptor in lung cancer |
| |
| KANG Bao-li,LU Ying and XU Zeng-guang. Research progress of Toll-like receptor in lung cancer[J]. Journal of Tongji University(Medical Science), 2015, 36(3): 140-144 |
| |
| Authors: | KANG Bao-li LU Ying XU Zeng-guang |
| |
| Affiliation: | Dept. of Research, East Hospital, Tongji University, Shanghai 200120, China,Dept. of Research, East Hospital, Tongji University, Shanghai 200120, China and Dept. of Research, East Hospital, Tongji University, Shanghai 200120, China |
| |
| Abstract: | Lung carcinoma is one of the leading causes of death worldwide. Despite advances in treatment, the prognosis remains poor.Toll-like receptors play a key role in the innate immune system. The recognition of specific molecules by TLRs leads to the activation of the adaptive immune system. The exogenous activation of the immune system via TLRs could on one side be a strategy to fight cancer, but on the other exacerbate, a latent chronic inflammation, which in turn, would further favour lung carcinoma progression. Recently, evidence has been accumulated to illustrate the molecular mechanisms by which these TLRs are functioning, so that to provide insight into the functional roles they may play in tumorigenesis. |
| |
| Keywords: | Toll-like receptors inflammation lung cancer immune system |
|
| 点击此处可从《同济大学学报(医学版)》浏览原始摘要信息 |
|
点击此处可从《同济大学学报(医学版)》下载全文 |
|
